Quantcast

Latest Embryology Stories

2014-10-16 12:29:34

EpiFix® shown to result in the most rapid improvement and resolution of DFUs, successful complex management of extensive life-threatening wounds, and safe and effective treatment of Stage IV Pressure Ulcers MARIETTA, Ga., Oct. 16, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG) EpiFix® dehydrated human amnion/chorion membrane (dHACM) allografts have been shown to be clinically effective in the treatment of hard-to-heal wounds such as diabetic foot ulcers (DFUs), pressure ulcers...

Nudibranch
2014-10-02 03:00:55

Kim McDonald, UC San Diego The evolution of worms, insects, vertebrates and other “bilateral” animals—those with distinct left and right sides—from less complex creatures like jellyfish and sea anemones with “radial” symmetry may have been facilitated by the emergence of a completely new "operating system" for controlling genetic instructions in the cell. That’s the hypothesis of molecular biologists at UC San Diego. They report in the October 1 issue of the journal Genes...

2014-09-08 16:25:56

MARIETTA, Ga., Sept. 8, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will be hosting and webcasting its Analyst Day on Tuesday, October 14, 2014, in New York, New York. Parker H. "Pete" Petit, Chairman and CEO; William C. Taylor, President and COO; Michael J. Senken, Chief Financial Officer; and...

2014-09-03 12:24:59

Study determines allografts with both amnion and chorion contain approximately 20 times more cytokines than the competitive single layer amnion allografts evaluated MARIETTA, Ga., Sept. 3, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today the publication of another peer-reviewed scientific study in the scientific...

2014-08-04 16:25:55

MARIETTA, Ga., Aug. 4, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the 34(th) Annual Canaccord|Genuity Growth Conference in Boston, Massachusetts. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are...

2014-07-17 12:30:30

CINCINNATI, July 17, 2014 /PRNewswire-USNewswire/ -- Scientists have identified a crucial molecular key to healthy embryo implantation and pregnancy in a study that may offer new clues about the medical challenges of infertility/subfertility, abnormal placentation, and placenta previa. http://photos.prnewswire.com/prnvar/20110406/MM79025LOGO Multi-institutional teams led by researchers at Cincinnati Children's Hospital Medical Center report their results in Cell Reports on July 17....

2014-07-15 12:28:51

Hoskins Joins Leading Doctors to Help Guide Americord's Innovations in Cord Blood Banking NEW YORK, July 15, 2014 /PRNewswire/ -- Americord announced today that Iffath Abbasi Hoskins, M.D. has joined the company's Advisory Board. Dr. Hoskins is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at NYU Langone Medical Center in New York City. She is a practicing obstetrician-gynecologist and a sub-specialist in maternal-fetal medicine, which focuses on...

2014-07-15 08:29:13

MARIETTA, Ga., July 15, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the second quarter, ended June 30, 2014, will be released before the opening of the market on Tuesday, July 29, 2014. MiMedx will host a live broadcast of its second quarter conference call on Tuesday, July 29, 2014, at...

2014-07-01 10:58:24

The Rockefeller University About seven days after conception, something remarkable occurs in the clump of cells that will eventually become a new human being. They start to specialize. They take on characteristics that begin to hint at their ultimate fate as part of the skin, brain, muscle or any of the roughly 200 cell types that exist in people, and they start to form distinct layers. Although scientists have studied this process in animals, and have tried to coax human embryonic...

Four Foals Born From Genotyped, Cryopreserved Embryos In Europe
2014-06-16 03:19:54

INRA Science & Impact IFCE and INRA announced that, for the first time ever in Europe, four foals were successfully born as the result of the transfer of genotyped and cryopreserved embryos. The goal of this work is to better understand embryonic development, control livestock reproduction, and maintain breed genetic diversity. Furthermore, it is advantageous for the horse industry to be able to determine the traits of a future foal. The INRA Val de Loire center at Nouzilly is where...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.